Asthma
Genaera Corporation Completes Strategic Review and Announces Plan to Focus Resources on Obesity and Asthma Programs
Published in Fitness and Wellness Business Week, April 25th, 2007
Genaera Corporation (NASDAQ:GENR) announced that its Board of Directors has approved management's plan to focus corporate resources on the development of trodusquemine (MSI-1436) for the treatment of obesity. Trodusquemine development, along with Genaera's partnership with MedImmune, Inc. on the development of anti-interleukin-9 (IL9) antibody for the treatment of asthma, will form the cornerstone of Genaera's research activities over the next year. In connection with this realignment, Genaera will reduce its workforce by approximately 30 percent over the next three months and pursue the divestiture of certain non-core assets.
"We have conducted an exhaustive review of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Acidosis Therapy
Study data from North Shore University update understanding of acidosis therapy - Adipose Tissue
Findings in adipose tissue reported from Chiba University - Alcoholism
Scientists at University of Sao Paulo, Department of Gastroenterology report research in alcoholism - Alcoholism Histology
Data from Kurume University advance knowledge in alcoholism histology - Altarum Institute
Our Health, Our Workforce: Can Michigan Make Employee Health a Competitive Advantage? - Bariatrics
RemedyMD Announces BariEHR for Bariatric Physicians Version 2.0 - the First EHR Designed for Bariatric Physicians and Integrated With Inventory and Invoicing - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
